LCZ-Mont Suspension
By LCZ-Mont
Rx
60ml Oral Suspension in a Bottle

Composition
Levocetirizine(5mg) + Montelukast(10mg)

Manufacturer - Rapross Pharmaceuticals Pvt Ltd
IInd Floor, Garg Plaza, 5 Community Centre, Sector-8, Rohini, Delhi-110085

Expires on or after
September, 2026

liver
LCZ-Mont Suspension should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of LCZ-Mont Suspension in these cases. It is advised to seek advice from a healthcare provider before using this medication if you have severe liver issues. There is limited data on the use of LCZ-Mont Suspension in individuals with liver problems. However, no dosage adjustment is typically required for those with mild to moderate liver disease. It is important to consult your doctor for guidance on the safe use of LCZ-Mont Suspension if you have any concerns about your liver health.

kidney
Caution should be taken when using LCZ-Mont Suspension in patients with kidney disease. Consult your doctor for possible dose adjustment. Avoid use in severe kidney disease.

alcohol
When consuming alcohol with LCZ-Mont Suspension, caution is advised. It is recommended to consult your doctor regarding the use of alcohol.

driving
When taking LCZ-Mont Suspension, be cautious about driving as it can reduce alertness, impact vision, causing drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
LCZ-Mont Suspension is generally safe to use in pregnancy. Animal studies showed minimal harm to the baby. Limited human studies available.

breastfeeding
LCZ-Mont Suspension is considered unsafe for use while breastfeeding due to potential risk of causing toxicity to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | RESPIRATORY |
| Action Class | - |
₹89.25
₹105
15% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025
